Press Releases + New

Date	Title and Summary	View
Toggle SummaryMar 09, 2011	PRO-PHARMACEUTICALS NAMES PETER G. TRABER, M.D., FORMER GLAXOSMITHKLINE CHIEF MEDICAL OFFICER & PRESIDENT EMERITUS OF BAYLOR COLLEGE OF MEDICINE, PRESIDENT & CHIEF EXECUTIVE OFFICER	View HTML PRO-PHARMACEUTICALS NAMES PETER G. TRABER, M.D., FORMER GLAXOSMITHKLINE CHIEF MEDICAL OFFICER & PRESIDENT EMERITUS OF BAYLOR COLLEGE OF MEDICINE, PRESIDENT & CHIEF EXECUTIVE OFFICER 19 KB
Toggle SummaryFeb 08, 2011	PRO-PHARMACEUTICALS TO PRESENT CORPORATE UPDATE AT BIO CEO & INVESTOR CONFERENCE	View HTML PRO-PHARMACEUTICALS TO PRESENT CORPORATE UPDATE AT BIO CEO & INVESTOR CONFERENCE 18 KB
Toggle SummaryJan 10, 2011	PRO-PHARMACEUTICALS RECEIVES POSITIVE FDA FEEDBACK ON DAVANAT® PHASE III CLINICAL TRIAL DESIGN TO TREAT PATIENTS WITH COLORECTAL CANCER	View HTML PRO-PHARMACEUTICALS RECEIVES POSITIVE FDA FEEDBACK ON DAVANAT® PHASE III CLINICAL TRIAL DESIGN TO TREAT PATIENTS WITH COLORECTAL CANCER 17.3 KB
Toggle SummaryJan 06, 2011	PRO-PHARMACEUTICALS CLOSES $2.1 MILLION OFFERING Warrant Exercises Generate Additional $1 Million	View HTML PRO-PHARMACEUTICALS CLOSES $2.1 MILLION OFFERING 16.8 KB
Toggle SummaryJan 04, 2011	PRO-PHARMACEUTICALS TO PRESENT CORPORATE UPDATE AT SAN FRANCISCO BIOTECH CONFERENCE	View HTML PRO-PHARMACEUTICALS TO PRESENT CORPORATE UPDATE AT SAN FRANCISCO BIOTECH CONFERENCE 16.5 KB
Toggle SummaryDec 21, 2010	PRO-PHARMACEUTICALS & MOUNT SINAI SCHOOL OF MEDICINE ANNOUNCE NEW LIVER FIBROSIS RESEARCH COLLABORATION	View HTML PRO-PHARMACEUTICALS & MOUNT SINAI SCHOOL OF MEDICINE ANNOUNCE NEW LIVER FIBROSIS RESEARCH COLLABORATION 22.5 KB
Toggle SummaryDec 07, 2010	PRO-PHARMACEUTICALS EXPANDS PATENT COVERAGE TO AUSTRALIA Patent Covers Use of DAVANAT® with Chemotherapy to Increase Effectiveness and Reduce Side Effects of Cancer Treatments	View HTML PRO-PHARMACEUTICALS EXPANDS PATENT COVERAGE TO AUSTRALIA 17.4 KB
Toggle SummaryNov 12, 2010	PRO-PHARMACEUTICALS REPORTS THIRD QUARTER 2010	View HTML PRO-PHARMACEUTICALS REPORTS THIRD QUARTER 2010 19.3 KB
Toggle SummaryNov 02, 2010	PRO-PHARMACEUTICALS TO RECEIVE $489,000 IN FEDERAL GRANTS FOR ITS GALECTIN-TARGETING CANCER AND LIVER FIBROSIS COMPOUNDS	View HTML PRO-PHARMACEUTICALS TO RECEIVE $489,000 IN FEDERAL GRANTS FOR ITS GALECTIN-TARGETING CANCER AND LIVER FIBROSIS COMPOUNDS 18.7 KB
Toggle SummaryOct 28, 2010	PRO-PHARMACEUTICALS SHIPS FIRST COMMERCIAL ORDER FOR DAVANAT® South American Distributor PROCAPS S.A. To Market and Sell DAVANAT® in Colombia, South America	View HTML PRO-PHARMACEUTICALS SHIPS FIRST COMMERCIAL ORDER FOR DAVANAT® 18.5 KB